Literature DB >> 18794055

Evaluation of FoxP3 expression in peripheral T-cell lymphoma.

Irina Bonzheim1, Eva Geissinger, Marianne Tinguely, Sabine Roth, Tina Grieb, Peter Reimer, Martin Wilhelm, Andreas Rosenwald, Hans Konrad Müller-Hermelink, Thomas Rüdiger.   

Abstract

Peripheral T-cell lymphomas (PTCLs) are biologically heterogeneous and have not been successfully correlated with specific T-cell subsets. We investigated PTCL, not otherwise specified (NOS), angioimmunoblastic T-cell lymphoma (AILT), and anaplastic large cell lymphoma (ALCL) cases for FoxP3 expression to determine a potential derivation from regulatory T (Treg) cells. One PTCL-NOS case strongly expressed FoxP3 in the neoplastic T cells and showed unusual histomorphologic features with a dense infiltration of the lymph node by immunoblastic T cells and almost no reactive background infiltrate. The patient died shortly after diagnosis, suggesting that biologic properties of Treg cells may have contributed to the rapidly fatal clinical course. All remaining PTCL-NOS and AILT cases showed FoxP3 positivity only in the reactive infiltrate. Among ALCL cases, 4 of 6 ALK+ cases displayed weak and inhomogeneous FoxP3 expression in the tumor cells. FoxP3+ PTCL-NOS presumably derived from bona fide Treg cells occurs but seems rare in the Western population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794055     DOI: 10.1309/L65GWEQ803PP6VX1

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.

Authors:  Claudio Tripodo; Giorgia Gri; Pier Paolo Piccaluga; Barbara Frossi; Carla Guarnotta; Silvia Piconese; Giovanni Franco; Valeria Vetri; Carlo Ennio Pucillo; Ada Maria Florena; Mario Paolo Colombo; Stefano Aldo Pileri
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

2.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-03       Impact factor: 0.196

3.  The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies.

Authors:  H A Sterle; M L Barreiro Arcos; E Valli; M A Paulazo; S P Méndez Huergo; A G Blidner; F Cayrol; M C Díaz Flaqué; A J Klecha; V A Medina; L Colombo; G A Rabinovich; G A Cremaschi
Journal:  J Mol Med (Berl)       Date:  2015-11-13       Impact factor: 4.599

Review 4.  The four types of Tregs in malignant lymphomas.

Authors:  Jing Wang; Xiao-Yan Ke
Journal:  J Hematol Oncol       Date:  2011-12-09       Impact factor: 17.388

5.  Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: no correlation with survival.

Authors:  Josefine Lundberg; David Berglund; Daniel Molin; Amelie Kinch
Journal:  Ups J Med Sci       Date:  2019-03-11       Impact factor: 2.384

6.  Notch1 signaling is involved in regulating Foxp3 expression in T-ALL.

Authors:  Xiaodan Luo; Huo Tan; Yueqiao Zhou; Tiantian Xiao; Chunyan Wang; Yangqiu Li
Journal:  Cancer Cell Int       Date:  2013-04-11       Impact factor: 5.722

7.  Challenging perspectives on the cellular origins of lymphoma.

Authors:  Tim I M Malcolm; Daniel J Hodson; Elizabeth A Macintyre; Suzanne D Turner
Journal:  Open Biol       Date:  2016-09       Impact factor: 6.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.